A detailed history of British Columbia Investment Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 422,607 shares of MRK stock, worth $42.2 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
422,607
Previous 485,103 12.88%
Holding current value
$42.2 Million
Previous $60.1 Million 20.09%
% of portfolio
0.3%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $6.95 Million - $8.06 Million
-62,496 Reduced 12.88%
422,607 $48 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $22.5 Million - $24.1 Million
181,520 Added 59.79%
485,103 $60.1 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $1.3 Million - $1.52 Million
11,485 Added 3.93%
303,583 $40.1 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $6.13 Million - $6.67 Million
61,191 Added 26.5%
292,098 $31.8 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $166,161 - $184,528
1,614 Added 0.7%
230,907 $23.8 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $280,322 - $305,538
2,581 Added 1.14%
229,293 $26.5 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $195,894 - $218,578
1,903 Added 0.85%
226,712 $24.1 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $2.25 Million - $2.89 Million
-25,781 Reduced 10.29%
224,809 $24.9 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $3.64 Million - $4.09 Million
-43,041 Reduced 14.66%
250,590 $21.6 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $8.06 Million - $9.14 Million
-96,565 Reduced 24.75%
293,631 $26.8 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $4.03 Million - $4.52 Million
-54,859 Reduced 12.33%
390,196 $32 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $1.68 Million - $2.1 Million
-23,182 Reduced 4.95%
445,055 $34.1 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $10,608 - $11,666
-148 Reduced 0.03%
468,237 $35.2 Million
Q2 2021

Aug 09, 2021

BUY
$70.31 - $77.77 $3.72 Million - $4.12 Million
52,949 Added 12.75%
468,385 $36.4 Million
Q1 2021

Apr 30, 2021

SELL
$68.86 - $81.11 $865,501 - $1.02 Million
-12,569 Reduced 2.94%
415,436 $32 Million
Q4 2020

Feb 02, 2021

SELL
$71.77 - $79.65 $748,274 - $830,430
-10,426 Reduced 2.38%
428,005 $35 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $2.32 Million - $2.63 Million
31,728 Added 7.8%
438,431 $36.4 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $9.03 Million - $10.3 Million
128,209 Added 46.04%
406,703 $31.5 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $20.6 Million - $28.6 Million
-325,701 Reduced 53.91%
278,494 $21.4 Million
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $16.2 Million - $18.3 Million
-209,109 Reduced 25.71%
604,195 $55 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $9.39 Million - $10.2 Million
-123,446 Reduced 13.18%
813,304 $68.5 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $5.98 Million - $6.99 Million
85,629 Added 10.06%
936,750 $78.5 Million
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $19.5 Million - $22.2 Million
-280,079 Reduced 24.76%
851,121 $70.8 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $9.58 Million - $11.1 Million
146,832 Added 14.92%
1,131,200 $86.4 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $17.8 Million - $20.9 Million
-308,329 Reduced 23.85%
984,368 $69.8 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $13.2 Million - $15.5 Million
-260,074 Reduced 16.75%
1,292,697 $78.5 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $6.13 Million - $7.13 Million
-120,364 Reduced 7.19%
1,552,771 $84.6 Million
Q4 2017

Feb 20, 2018

SELL
$51.62 - $61.64 $6.17 Million - $7.37 Million
-119,622 Reduced 6.67%
1,673,135 $94.1 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $105 Million - $113 Million
1,792,757
1,792,757 $115 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.